Evolving concepts of cardiac valve dynamics: The continuum of development, functional structure, pathobiology, and tissue engineering

Circulation

Volumn 118, Issue 18, 2008, Pages 1864-1880

  Schoen, Frederick J ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Aortic valve; Mitral valve; Pathology; Prosthesis; Tissue engineering

Indexed keywords

ALLOGRAFT; AORTA VALVE; AORTA VALVE STENOSIS; AUTOGRAFT; BICUSPID AORTIC VALVE; BIOMECHANICS; CELL MATURATION; CELL STRUCTURE; CONGENITAL MALFORMATION; CYTOLOGY; DEVELOPMENTAL BIOLOGY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HEART FUNCTION; HEART MYXOMA; HEART VALVE; HEART VALVE PROSTHESIS; HOMEOSTASIS; HUMAN; MITRAL VALVE; MITRAL VALVE PROLAPSE; ORGAN; PATHOLOGY; PRIORITY JOURNAL; REVIEW; TISSUE; TISSUE ENGINEERING; TISSUE REGENERATION; VALVULAR HEART DISEASE;

ANIMALS; BIOPROSTHESIS; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HEART VALVES; HUMANS; TISSUE ENGINEERING;

EID: 56749158817     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.108.805911     Document Type: Review

References (144)

1. Yacoub MH, Cohn LH. Novel approaches to cardiac valve repair, from structure to function: parts I and II. Circulation. 2004;109:942-950, 1064-1072.
2. Vesely I. Heart valve tissue engineering. Circ Res. 2005;97:743-755.
3. Mendelson K, Schoen FJ. Heart valve tissue engineering: concepts, approaches, progress, and challenges. Ann Biomed Eng. 2006;34:1799-1819.
4. Schoen FJ. New frontiers in the pathology and therapy of heart valve disease. Cardiovasc Pathol. 2006;15:271-279.
5. Misfeld M, Sievers H-H. Heart valve macro- and microstructure. Phil Trans R Soc B. 2007;362:1421-1436.
6. Weind KL, Ellis CG, Boughner DR. Aortic valve cusp vessel density: relationship with tissue thickness. J Thorac Cardiovasc Surg. 2002;123:333-340.
7. Yoshioka M, Yuasa S, Matsumura K, Kimura K, Shiomi T, Kimura N, Shukunami C, Okada Y, Mukai M, Shin H, Yozu R, Sata M, Ogawa S, Hiraki Y, Fukuda K. Chondromodulin-I maintains cardiac valvular function by preventing angiogenesis. Nat Med. 2006;12:1151-1159.
8. Marron K, Yacoub MH, Polak JM, Sheppard MN, Fagan D, Whitehead BF, de Leval MR, Anderson RH, Wharton J. Innervation of human atrioventricular and arterial valves. Circulation. 1996;94:368-375.
9. Chester AH, Misfeld M, Yacoub MH. Receptor-mediated contraction of aortic valve leaflets. J Heart Valve Dis. 2000;9:250-255.
10. Kershaw JD, Misfeld M, Sievers HH, Yacoub MH, Chester AH. Specific regional and directional contractile responses of aortic cusp tissue. J Heart Valve Dis. 2004;13:798-803.
11. Schoen FJ. Aortic valve structure-function correlations: role of elastic fibers no longer a stretch of the imagination. J Heart Valve Dis. 1997;6:1-6.
12. Hubert SL, Barrick MK, Ferrans VJ. Porcine aortic valve bioprostheses: a morphologic comparison of the effects of fixation pressure. J Biomed Mater Res. 1990;24:773-787.
13. Flomenbaum MA, Schoen FJ. Effects of fixation backpressure and antimineralization treatment on the morphology of porcine aortic bioprosthetic valves. J Thorac Cardiovasc Surg. 1993;105:154-164.
14. Sacks MS, Smith DB, Hiester ED. The aortic valve microstructure: effects of transvalvular pressure. J Biomed Mater Res. 1998;41:131-141.
15. Sacks MS, Yoganathan AP. Heart valve function: a biomechanical perspective. Phil Trans R Soc B. 2007;362:1369-1391.
16. Lo D, Vesely I. Biaxial strain analysis of the porcine aortic valve. Ann Thorac Surg. 1995;60:S374-S378.
17. Vesely I. Reconstruction of loads in the fibrosa and ventricularis of porcine aortic valves. ASAIO J. 1996;42:M739-M746.
18. Stella JA, Sacks MS. On the biaxial mechanical properties of the layers of the aortic valve leaflet. J Biomech Eng. 2007;129:757-766.
19. Mirnajafi A, Raymer JM, McClure LR, Sacks MS. The flexural rigidity of the aortic valve leaflet in the commissural region. J Biomech. 2006; 39:2966-2973.
20. Bashey RI, Bashey HM, Jimenez SA. Characterization of pepsin-solubilized bovine heart-valve collagen. Biochem J. 1978;173:203-208.
21. Bashey RI, Torii S, Angrist A. Age-related collagen and elastin content of human heart valves. J Gerontol. 1967;22:203-208.
22. Mulholland DL, Gotlieb AI. Cell biology of the valvular interstitial cells. Can J Cardiol. 1996;12:231-236.
23. Dreger SA, Taylor PM, Allen SP, Yacoub MH. Profile and localization of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in human heart valves. J Heart Valve Dis. 2002;11:875-880.
24. Liu AC, Joag VR, Gotlieb AI. The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology. Am J Pathol. 2007;171:1407-1418.
25. Hinz B, Phan SH, Thannickal VJ, Galli A, Bochaton-Piallat M-L, Gabbiani G. The myofibroblast: one function, multiple origins. Am J Pathol. 2007;170:1807-1816.
26. Walker GA, Masters KS, Shah DN, Anseth KS, Leinwand LA. Valvular myofibroblast activation by transforming growth factor beta: implications for pathological extracellular matrix remodeling in heart valve disease. Circ Res. 2004;95:253-260.
27. Chester A, Taylor PM. Molecular and functional characteristics of heart-valve interstitial cells. Phil Trans R Soc B. 2007;362:1437-1443.
28. Balachandran K, Konduri S, Sucosky P, Jo H, Yoganathan AP. An ex vivo study of biological properties of porcine aortic valves in response to circumferential cyclic stretch. Ann Biomed Eng. 2006;34:1655-1665.
29. Gupta V, Werdenberg JA, Lawrence BD, Mendez JS, Stephens EH, Grande-Allen KJ. Reversible secretion of glycosaminoglycans and proteoglycans by cyclically stretched valvular cells in 3D culture. Ann Biomed Eng. 2008;36:1092-1103.
30. Merryman WD, Lukoff HD, Long RA, Engelmayr GC Jr, Hopkins RA, Sacks MS. Synergistic effects of cyclic tension and transforming growth factor beta1 on the aortic valve myofibroblast. Cardiovasc Pathol. 2007;16:268-276.
31. Merryman WD, Youn I, Lukoff HD, Krueger PM, Guilak F, Hopkins RA, Sacks MS. Correlation between heart valve interstitial cell stiffness and transvalvular pressure: implications for collagen biosynthesis. Am J Physiol. 2006;290:H224-H231.
32. Butcher JT, Simmons CA, Waraock JN. Mechanobiology of the aortic heart valve. J Heart Valve Dis. 2008;17:62-73.
33. Merryman WD, Liao J, Parekh A, Candiello JE, Lin H, Sacks MS. Differences in tissue-remodeling potential of aortic and pulmonary heart valve interstitial cells. Tissue Eng. 2007;13:2281-2289.
34. Blevins TL, Peterson SB, Lee EL, Bailey AM, Frederick JD, Huynh TN, Gupta V, Grande-Allen KJ. Mitral valve interstitial cells demonstrate regional, adhesional, and synthetic heterogeneity. Cells Tissues Organs. 2008;187:113-122.
35. Gupta V, Werdenberg JA, Blevins TL, Grande-Allen KJ. Synthesis of glycosaminoglycans in differently loaded regions of collagen gels seeded with valvular interstitial cells. Tissue Eng. 2008;13:41-49.
36. Aird WC. Phenotype heterogeneity of the endothelium, I: Structure, function, and mechanisms. II. Representative vascular beds. Circ Res. 2007;100:158-173, 174-190.
37. Butcher JT, Nerem RM. Valvular endothelial cells regulate the phenotype of interstitial cells in co-culture: effects of steady shear stress. Tissue Eng. 2006;12:905-915.
38. Butcher JT, Penrod AM, Garcia AJ, Nerem RM. Unique morphology and focal adhesion development of valvular endothelial cells in static and fluid flow environments. Arterioscler Thromb Vasc Biol. 2004;24:1429-1434.
39. Butcher JT, Tressel S, Johnson T, Turner D, Sorescu G, Jo H, Nerem RM. Transcriptional profiles of valvular and vascular endothelial cells reveal phenotypic differences: influence of shear stress. Arterioscler Thromb Vasc Biol. 2006;26:69-77.
40. Simmons CA, Grant GR, Mandachi E, Davies PF. Spatial heterogeneity of endothelial phenotypes correlates with side-specific vulnerability to calcification in normal porcine aortic valves. Circ Res. 2005;96:792-799.
41. Srivastava D. Making or breaking the heart: from lineage determination to morphogenesis. Cell. 2006;126:1037-1048.
42. Bruneau BG. The developmental genetics of congenital heart disease. Nature. 2008;451:943-948.
43. Hinton RB Jr, Lincoln J, Deutsch GH, Osinska H, Manning PB, Benson DW, Yutzey KE. Extracellular matrix remodeling and organization in developing and diseased aortic valves. Circ Res. 2006;98:1431-1438.
44. Armstrong EJ, Bischoff J. Heart valve development: endothelial cell signaling and differentiation. Circ Res. 2004;95:459-470.
45. Butcher JT, Markwald RR. Valvulogenesis: the moving target. Phil Trans R Soc B. 2007;362:1489-1503.
46. Sata M. Role of circulating vascular progenitors in angiogenesis, vascular healing, and pulmonary hypertension: lessons from animal models. Arterioscler Thromb Vasc Biol. 2006;26:1008-1014.
47. Visconti RP, Ebihara Y, LaRue AC, Fleming PA, McQuinn TC, Masuya M, Minamiguchi H, Markwald RR, Ogawa M, Drake CJ. An in vivo analysis of hematopoietic stem cell potential: hematopoietic origin of cardiac valve interstitial cells. Circ Res. 2006;98:690-696.
48. Deb A, Wang SH, Skelding K, Miller D, Simper D, Caplice N. Bone marrow-derived myofibroblasts are present in adult human heart valves. J Heart Valve Dis. 2005;14:674-678.
49. Person AD, Klewer SE, Runyan RB. Cell biology of cardiac cushion development. Int Rev Cytol. 2005;243:287-335.
50. Camenisch TD, Schroeder JA, Bradley J, Klewer SE, McDonald JA. Heart-valve mesenchyme formation is dependent on hyaluronan-augmented activation of ErbB2-ErbB3 receptors. Nat Med. 2002;8:850-855.
51. Norris RA, Moreno-Rodriguez RA, Sugi Y, Hoffman S, Amos J, Hart MM, Potts JD, Goodwin RL, Markwald RR. Periostin regulates atrioventricular valve maturation. Dev Biol. 2008;316:200-213.
52. Bartman T, Hove J. Mechanics and function in heart morphogenesis. Dev Dynamics. 2005;233:373-381.
53. Butcher JT, McQuinn TC, Sedmera D, Turner D, Markwald RR. Transitions in early embryonic atrioventricular valvular function correspond with changes in cushion biomechanics that are predictable by tissue composition. Circ Res. 2007;100:1503-1511.
54. Scherz PJ, Huisken J, Sahai-Hernandez P, Stainier DYR. High-speed imaging of developing heart valves reveals interplay of morphogenesis and function. Development. 2008;135:1179-1187.
55. Hove JR, Koster RW, Forouhar AS, Acevedo-Bolton G, Fraser SE, Gharib M. Intracardiac fluid forces are an essential epigenetic factor for embryonic cardiogenesis. Nature. 2003;421:172-177.
56. Bartman T, Walsh EC, Wen KK, McKane M, Ren J, Alexander J, Rubenstein PA, Stainier DY. Early myocardial function effects endocardial cushion development in zebrafish. PloS Biol. 2004;2:673-681.
57. Keller BB. New insights into the developmental biomechanics of the atrioventricular valves. Circ Res. 2007;100:1399-1401.
58. Aikawa E, Whittaker P, Farber M, Mendelson K, Padera RF, Aikawa M, Schoen FJ. Human semilunar cardiac valve remodeling by activated cells from fetus to adult. Circulation. 2006;113:1344-1352.
59. Christie GW, Barratt-Boyes BG. Age-dependent changes in the radial stretch of human aortic valve leaflets determined by biaxial testing. Ann Thorac Surg. 1995;60:S156-S158.
60. Rabkin E, Aikawa M, Stone JR, Fukumoto Y, Libby P, Schoen FJ. Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves. Circulation. 2001;104:2525-2532.
61. Rabkin-Aikawa E, Aikawa M, Farber M, Kratz JR, Garcia-Cardena G, Kouchoukos NT, Mitchell MB, Jones RA, Schoen FJ. Clinical pulmonary autograft valves: Pathologic evidence of adaptive remodeling in the aortic site. J Thorac Cardiovasc Surg. 2004;128:552-561.
62. Rabkin-Aikawa E, Farber M, Aikawa M, Schoen FJ. Dynamic and reversible changes of interstitial cell phenotype during development and remodeling of cardiac valves. J Heart Valve Dis. 2004;13:841-847.
63. Hill JA, Olson EN. Cardiac plasticity. N Engl J Med. 2008;358:1370-1380.
64. Connolly HM, Crary JL, McGoon MD, Hensrud DD, Edwards BS, Edwards WD, Schaff HV. Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med. 1997;337:581-588.
65. Roth BL. Drugs and valvular heart disease. N Engl J Med. 2007;356:6-9.
66. Home BD, Camp NJ, Muhlestein JB, Cannon-Albright LA. Evidence for a heritable component in death resulting from aortic and mitral valve disease. Circulation. 2004;110:3143-3148.
67. Cripe L, Andelfinger G, Martin LJ, Shooner K, Benson DW. Bicuspid aortic valve is heritable. J Am Coll Cardiol. 2004;44:138-143.
68. Robinson PN, Arteaga-Solia E, Baldock C, Collod-Beroud G, Booms P, De Paepe A, Dietz HC, Guo G, Handford PA, Judge DP, Kielty CM, Loeys B, Milewicz DM, Ney A, Ramirez F, Reinhardt DP, Tiedemann K, Whiteman P, Godfrey M. The molecular genetics of Marfan syndrome and related disorders. J Med Genet. 2006;43:769-787.
69. Fedak PWM, David TE, Borger M, Verma S, Butany J Weisel RD. Bicuspid aortic valve disease: recent insights in pathophysiology and treatment. Expert Rev Cardiovasc Ther. 2005;3:295-308.
70. Lewin MB, Otto CM. The bicuspid aortic valve: adverse outcomes from infancy to old age. Circulation. 2005;111:832-834.
71. Roberts WC, Ko JM. Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation. 2005;111:920-925.
72. Garg V, Muth AN, Ransom JF, Schluterman MK, Barnes R, King IN, Grossfeld PD, Srivastava D. Mutations in NOTCH1 cause aortic valve disease. Nature. 2005;437:270-274.
73. Otto CM. Valvular aortic stenosis: disease severity and timing of intervention. J Am Coll Cardiol. 2006;47:2141-2151.
74. Thubrikar MJ, Aouad J, Nolan SP. Patterns of calcific deposits in operatively excised stenotic or purely regurgitant aortic valves and their relation to mechanical stress. Am J Cardiol. 1986;58:304-308.
75. Kim KM. Calcification of matrix vesicles in human aortic valve and aortic media. Fed Proc. 1976;35:156-162.
76. Otto CM. Calcific aortic stenosis - time to look more closely at the valve. N Engl J Med. 2008;359:1395-1398.
77. Goldbarg SH, Elmariah S, Miller MA, Fuster V. Insights into degenerative aortic valve disease. J Am Coll Cardiol. 2007;50:1205-1213.
78. Demer LL, Tintut Y. Vascular calcification: pathobiology of a multi-faceted disease. Circulation. 2008;117:2938-2948.
79. Drolet M-C, Arsenault M, Couet J. Experimental aortic valve stenosis in rabbits. J Am Coll Cardiol. 2003;41:1211-1217.
80. Aikawa E, Nahrendorf M, Figueiredo J-L, Swirski FK, Shtatland T, Kohler RH, Jaffer FA, Aikawa M, Weissleder R. Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo. Circulation. 2007;116:2841-2850.
81. Cowell SJ, Newby DE, Prescott RJ, Bloomfield P, Reid J, Northridge DB, Boon NA; Scottish Aortic Stenosis and Lipid Lowering Trial, Impact on Regression (SALTIRE) Investigators. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med. 2005;352:2389.
82. Mohler ER III, Wang H, Medenilla E, Scott C. Effect of statin treatment on aortic valve and coronary artery calcification. J Heart Valve Dis. 2007;16:378-386.
83. Verma S, Szmitko PE, Fedak PW, Errett L, Latter DA, David TE. Can statin therapy alter the natural history of bicuspid aortic valves? Am J Physiol. 2005;288:H2547.
84. Aubin JE. Regulation of osteoblast formation and function. Rev Endocr Metab Dis. 2001;2:81-94.
85. Lincoln J, Lange AW, Yutzey KE. Hearts and bones: shared regulatory mechanisms in heart valve, cartilage, tendon, and bone development. Dev Biol. 2006;294:292-302.
86. Mohler ER III, Gannon F, Reynolds C, Zimmerman R, Keane MG, Kaplan FS. Bone formation and inflammation in cardiac valves. Circulation. 2001;103:1522-1528.
87. Rajamannan NM, Subramaniam M, Rickard D, Stock SR, Donovan J, Springen M, Orszulak T, Fullerton DA, Tajik AJ, Bonow RO, Spelsberg T. Human aortic valve calcification is associated with osteoblast phenotype. Circulation. 2003;107:2181-2184.
88. Osman L, Yacoub MH, Latif N, Amrani M, Chester AH. Role of human valve interstitial cells in valve calcification and their response to atorvastatin. Circulation. 2006;114:1547-1552.
89. Jian B, Jones PL, Li Q, Mohler ER III, Schoen FJ, Levy RJ. Matrix metalloproteinase-2 is associated with tenascin-C in calcific aortic stenosis. Am J Pathol. 2001;159:321-327.
90. Bosse Y, Matthieu P, Pibarot P. Genomics: the next step to elucidate the etiology of calcific aortic stenosis. J Am Coll Cardiol. 2008;51:1327-1336.
91. Steitz SA, Speer MY, McKee MD, Liaw L, Almeida M, Yang H, Giachelli CM. Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification. Am J Pathol. 2002;161:2035-2046.
92. Rajamannan NM, Subramaniam M, Springett M, Sebo TC, Niekrasz M, McConnell JP, Singh RJ, Stone NJ, Bonow RO, Spelsberg TC. Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve. Circulation. 2002;105:2660-2665.
93. Dai G, Kaaempur-Mofrad MR, Natarajan S, Zhang Y, Vaughn S, Blackman BR, Kamm RD, Garcia-Cardena G, Gimbrone MA Jr. Distinct endothelial phenotypes evoked by arterial waveforms derived from atherosclerosis-susceptible and -resistant regions of human vasculature. Proc Natl Acad Sci U S A. 2004;101:14871-14876.
94. Parmar KM, Larman HB, Dai G, Zhang Y, Wang ET, Moorthy SN, Kratz JR, Lin Z, Jain MK, Gimbrone MA Jr, Garcia-Cardena G. Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2. J Clin Invest. 2006;116:49-58.
95. Hayek E, Gring CN, Griffin BP. Mitral valve prolapse. Lancet. 2005;365:507-518.
96. Barber JE, Kasper FK, Ratliff NB, Cosgrove DM, Griffin BP, Vesely I. Mechanical properties of myxomatous mitral valves. J Thorac Cardiovasc Surg. 2001;122:955-962.
97. Grande-Allen KJ, Griffin BP, Ratliff NB, Cosgrove DM, Vesely I. Glycosaminoglycan profiles of myxomatous mitral leaflets and chordae parallel the severity of mechanical alterations. J Am Coll Cardiol. 2003;42:271-277.
98. Tamura K, Fukuda Y, Ishizaki M, Masuda Y, Yamanaka N, Ferrans VJ. Abnormalities in elastic fibers and other connective-tissue components of floppy mitral valve. Am Heart J. 1995;129:1149-1158.
99. Nasuti JF, Zhang PJ, Feldman MD, Pasha T, Khuana JS, Gorman JH III, Gorman RC, Narula J, Narula N. Fibrillin and other matrix proteins in mitral valve prolapse syndrome. Ann Thorac Surg. 2004;77:532-536.
100. Roberts R. Another chromosomal locus for mitral valve prolapse: close but no cigar. Circulation. 2005;112:1924-1926.
101. Wynn TA. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest. 2007;117:524-529.
102. Trochu JN, Kyndt F, Schott JJ, Gueffet JP, Probst V, Benichou B, Le Marec H. Clinical characteristics of a familial inherited myxomatous valvular dystrophy mapped to Xq28. J Am Coll Cardiol. 2000;35:1890-1897.
103. Freed LA, Acierno JS Jr, Dai D, Leyne M, Marshall JE, Nesta F, Levine RA, Slaugenhaupt SA. A local for autosomal dominant mitral valve prolapse on chromosome 11p15.4. Am J Hum Genet. 2003;72:1551-1559.
104. Disse S, Abergel E, Berrebi A, Houot AM, Le Heuzey JY, Diebold B, Guize L, Carpentier A, Corvol P, Jeunemaitre X. Mapping of a first locus for autosomal dominant myxomatous mitral-valve prolapse to chromosome 16p11.2-p12.1. Am J Hum Genet. 1999;65:1242-1251.
105. Nesta F, Leyne M, Yosefy C, Simpson C, Dai D, Marshall JE, Huang J, Slaugenhaupt SA, Levine RA. New locus for autosomal dominant mitral valve prolapse on chromosome 13: clinical insights from genetic studies. Circulation. 2005;112:2022-2030.
106. Lifton RP. Lasker Award to heart valve pioneers. Cell. 2007;130:971-974.
107. El Oakley R, Kleine P, Bach DS. Choice of prosthetic heart valve in today's practice. Circulation. 2008;117:253-256.
108. Schoen FJ, Levy RJ. Calcification of tissue heart valve substitutes: progress toward understanding and prevention. Ann Thorac Surg. 2005;79:1072-1080.
109. Mitchell RN, Jonas RA, Schoen FJ. Pathology of explanted cryopreserved allograft heart valves: comparison with aortic valves from orthotopic heart transplants. J Thorac Cardiovasc Surg. 1998;115:118-127.
110. Vesely I, Boughner D, Song T. Tissue buckling as a mechanism of bioprosthetic valve failure. Ann Thorac Surg. 1988;46:302-308.
111. Fisher J, Davies GA. Buckling in bioprosthetic valves. Ann Thorac Surg. 1989;48:147-148.
112. Levy RJ, Schoen RJ, Levy JT, Nelson AC, Howard SL, Oshry LJ. Biologic determinants of dystrophic calcification and osteocalcin deposition in glutaraldehyde-preserved porcine aortic valve leaflets implanted subcutaneously in rats. Am J Pathol. 1983;113:142-155.
113. Schoen FJ, Levy RJ, Nelson AC, Bernhard WF, Nashef A, Hawley M. Onset and progression of experimental bioprosthetic heart valve calcification. Lab Invest. 1985;52:523-532.
114. Schoen FJ, Tsao JW, Levy RJ. Calcification of bovine pericardium used in cardiac valve bioprostheses: implications for mechanisms of bioprosthetic tissue mineralization. Am J Pathol. 1986;23:143-154.
115. Valente M, Bortolotti U, Thiene G. Ultrastructural substrates of dystrophic calcification in porcine bioprosthetic valve failure. Am J Pathol. 1985;119:12.
116. Bailey MT, Pillarisetti S, Xiao H, Vyavahare NR. Role of elastin in pathologic calcification of xenograft heart valves. J Biomed Mater Res. 2003;66:93-102.
117. Vesely I, Barber JE, Ratliff NB. Tissue damage and calcification may be independent mechanisms of bioprosthetic heart valve failure. J Heart Valve Dis. 2001;10:471-477.
118. Sacks MS, Schoen FJ. Collagen fiber disruption occurs independent of calcification in clinically explanted bioprosthetic heart valves. J Biomed Mater Res. 2002;62:359-371.
119. Lovekamp JJ, Simionescu DT, Mercuri JJ, Zubiate B, Sacks MS, Vyavahare NR. Stability and function of glycosaminoglycans in porcine bioprosthetic heart valves. Biomaterials. 2006;27:1507-1518.
120. Shah SR, Vyavahare NR. The effect of glycosaminoglycan stabilization on tissue buckling in bioprosthetic heart valves. Biomaterials. 2008;29:1645-1653.
121. Sacks MS, Engelmayr GC, Hildebrand D. Bioreactors for heart valve tissue engineering. In: Chaduri J, Al-Rubeai, M, eds. Bioreactors for Tissue Engineering. Dordrecht, Netherlands: Springer; 2005:235-267.
122. Hoerstrup SP, Sodian R, Daebritz S, Wang J, Bacha EA, Martin DA, Moran AM, Guleserian KJ, Sperling JS, Kaushal S, Vacanti JP, Schoen FJ, Mayer JE. Functional living trileaflet heart valves grown in vitro. Circulation. 2000;102:III-44-III-49.
123. Sutherland FWH, Perry TE, Yu Y, Sherwood MC, Rabkin E, Masuda Y, Garcia GA, McLellan DL, Engelmayr GC, Sacks MS, Schoen FJ, Mayer JE. From stem cells to viable autologous semilunar heart valve. Circulation. 2005;111:2783-2791.
124. Shin'oka T, Matsumura G, Hibino N, Naito Y, Watanabe M, Konuma T, Sakamoto T, Nagatsu M, Kurosawa H. Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. J Thorac Cardiovasc Surg. 2005;129:1330-1338.
125. Hoerstrup SP, Cummings I, Lachat M, Schoen FJ, Jenni R, Leschka S, Neuenschwander S, Schmidt D, Mol A, Gunter C, Gossi M, Genoni M, Zund G. Functional growth in tissue engineered living, vascular grafts: follow-up to 100 weeks in a large animal model. Circulation. 2006;114:159-166.
126. Robinson PS, Johnson SL, Evans MC, Barocas VH, Tranquillo RT. Functional tissue-engineered valves from cell-remodeled fibrin with commissural alignment of cell-produced collagen. Tissue Eng Part A. 2008;14:83-95.
127. Masters KS, Shah DN, Leinwand LA, Anseth KS. Crosslinked hyaluronan scaffolds as a biologically active carrier for valvular interstitial cells. Biomaterials. 2005;26:2517-2525.
128. Hayashida K, Kanda K, Yaku H, Ando J, Nadayama Y. Development of an in vivo tissue-engineered, autologous heart valve (the biovalve): preparation of a prototype model. J Thorac Cardiovasc Surg. 2007;134:152-159.
129. Hayashida K, Kanda K, Oie T, Okamoto Y, Ishibashi-Ueda H, Onoyama M, Tajikawa T, Ohba K, Yaku H, Nakayama Y. Architecture of an in-vivo tissue engineered autologous conduit "biovalve." J Biomed Mater Res Part B: Appl Biomater. 2008;86B:1-8.
130. de Vissscher G, Vranken I, Lebacq A, Van Kerrebroeck C, Ganame J, Verbeken E, Flameng W. In-vivo cellularization of a cross-linked matrix by intraperitoneal implantation: a new tool in heart valve tissue engineering. Eur Heart J. 2007;28:1389-1396.
131. Shi Y, Rittman L, Vesely I. Novel geometries for tissue-engineered tendonous collagen constructs. Tissue Eng. 2006;12:2601-2609.
132. Brody S, Pandit A. Approaches to heart valve tissue engineering scaffold design. J Biomed Mater Res B Appl Biomater. 2007;83:16-43.
133. Cebotari S, Lichtenberg A, Tudorache I, Hilfiker A, Mertsching H, Leyh R, Breymann T, Kallenbach K, Maniuc L, Batrinac A, Repin O, Maliga O, Ciubotaru A, Haverich A. Clinical application of tissue engineered human heart valves using autologous progenitor cells. Circulation. 2006;114:I-132-I-137.
134. Dohmen PM, Lembcke A, Holinski S, Kivelitz D, Braun JP, Pruss A, Konertz W. Mid-term clinical results using a tissue-engineered pulmonary valve to reconstruct the right ventricular outflow tract during the Ross procedure. Ann Thorac Surg. 2007;84:729-736.
135. Simon P, Kasimirr MT, Seebacher G, Weigel G, Ullrich R, Salzer-Muhar U, Rieder E, Wolner E. Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients. Eur J Cardiothorac Surg. 2003;23:1002-1006.
136. Matheny RG. Hutchison ML. Dryden PE. Hiles MD. Shaar CJ. Porcine small intestine submucosa as a pulmonary valve leaflet substitute. J Heart Valve Dis. 2000;9:769-775.
137. Kumar V. Abbas AK, Fausto N, eds. Robbins and Cotran Pathologie Basis of Disease. 7th ed. New York, NY: Elsevier-Saunders; 2004:53-62.
138. Schatteman GC, Dunnwald M, Jiao C. Biology of bone marrow-derived endothelial cell precursors. Am J Physiol. 2O07;292:Hl-H18.
139. Shantsila E. Watson T, Lip GYH. Endothelial progenitor cells in car-diovascular disorders. J Am Coll Cardiol. 2007;49:741-752.
140. Schmidt A, Brixius K. Bloch W. Endothelial precursor cell migration during vasculogenesis. Circ Res. 2007;101:125-136.
141. Ota T, Sawa Y, Iwai S, Kitajima T, Ueda Y, Coppin C, Matsuda H, Okita Y. Fibronectin-hepatocyte growth factor enhances reendothelialization in tissue-engineered heart valve. Ann Thorac Surg. 2005;80:1794-1801.
142. Aoki J, Serruys PW, van Beusekom H, Ong AT. McFadden EP, Sianos G, van der Giessen WJ, Regar E, de Feyter PJ, Davis HR, Rowland S, Kutryk MJ. Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry. J Am Coll Cardiol. 2005;45:1574-1579.
143. Rotmans JI, Heyligers JMM, Verhagen HJM, Velema E, Nagtegaal MM, de Kleijn DPV, de Groot FG, Stroes ESG, Pasterkamp G. In vivo cell seeding with anti-CD34 antibodies successfully accelerates endothelialization but stimulates initial hyperplasia in porcine arteriovenous expanded polytetrafluoroethylene grafts. Circulation. 2005;112:12-18.
144. Markway BD, McCarty OJT, Marzec UM, Courtman DW, Hanson SR, Hinds MT. Capture of flowing endothelial cells using surface-immobilized anti-kinase insert domain receptor antibody. Tissue Eng: Part C. 2008;14:97-105.